Sorry but this is immunotherapy that has to do with blood, the vaccine goes into the bloodstream to activate the immune system, does not work by using the vaccine near the genitals into the flesh
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
AVR
anteris technologies global corp.
Add to My Watchlist
3.93%
!
$5.62

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-347
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.62 |
Change
-0.230(3.93%) |
Mkt cap ! $87.13M |
Open | High | Low | Value | Volume |
$5.86 | $5.86 | $5.55 | $70.40K | 12.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 737 | $5.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.10 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 737 | 5.620 |
2 | 3032 | 5.560 |
1 | 180 | 5.550 |
1 | 3045 | 5.510 |
5 | 4811 | 5.500 |
Price($) | Vol. | No. |
---|---|---|
6.100 | 500 | 1 |
6.200 | 170 | 1 |
6.300 | 100 | 1 |
6.400 | 450 | 2 |
6.550 | 1092 | 1 |
Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |